Related Experiment Videos

Natriuretic peptides regulate the expression of tissue factor and PAI-1 in endothelial cells

M Yoshizumi1, H Tsuji, H Nishimura

  • 1Second Department of Medicine, Kyoto Prefectural University of Medicine, Japan. yoshizum@dc4.so-net.ne.jp

Thrombosis and Haemostasis
|December 14, 1999
PubMed

Insights

Brain natriuretic peptide (BNP) and C-type natriuretic peptide (CNP) regulate blood coagulation by suppressing angiotensin II-induced tissue factor (TF) and plasminogen activator inhibitor-1 (PAI-1) expression.

Area of Science:

  • Cardiovascular Physiology
  • Endocrinology
  • Hemostasis and Thrombosis

Background:

  • Angiotensin II (Ang II) plays a critical role in regulating blood pressure and fluid balance.
  • Ang II can induce pro-coagulant and anti-fibrinolytic factors, potentially contributing to thrombotic events.
  • Natriuretic peptides, including BNP and CNP, are known for their vasodilatory and diuretic effects.

Purpose of the Study:

  • To investigate the interaction between natriuretic peptides (BNP and CNP) and Ang II in the regulation of blood coagulation and fibrinolysis.
  • To determine the effect of BNP and CNP on Ang II-induced expression of key hemostatic factors.

Main Methods:

  • Analysis of tissue factor (TF) and plasminogen activator inhibitor-1 (PAI-1) mRNA expression using northern blotting.
  • Measurement of TF activity on rat aortic endothelial cells (RAECs) via chromogenic assay.
  • Quantification of PAI-1 activity in culture media using chromogenic assay.

Main Results:

  • BNP and CNP significantly suppressed Ang II-induced TF and PAI-1 mRNA expression in a time- and concentration-dependent manner.
  • The suppression of mRNA expression by BNP and CNP was mediated via the cyclic guanosine monophosphate (cGMP) cascade.
  • These suppressions were associated with decreased TF and PAI-1 activities.
  • Neither TFPI nor TPA mRNA expression was affected by BNP and CNP treatment.

Conclusions:

  • BNP and CNP exert anticoagulant and profibrinolytic effects by inhibiting Ang II-mediated TF and PAI-1 induction.
  • The cGMP pathway is involved in the inhibitory actions of BNP and CNP on TF and PAI-1 expression.
  • These findings highlight a novel interaction between natriuretic peptides and the renin-angiotensin system in hemostasis regulation.

Related Concept Videos